Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > Financing - 54 Cents

<< Previous

Bullboard Posts

Next >>

Comment by LakeErieon Jan 31, 2013 1:49pm

174 Views

Post# 20918813

RE: RE: Financing - 54 Cents

Mr. Duchebaggie - Yes I believe it is part of a communication strategy. They will put out the "above average" 43-101 just before PDAC to drum up word of mouth.

Who does not like going to party and being the one talked about and fawned over.......would you visit a booth where the company is bust or the company that just said they had 3 million ozs in the ground and more possible coming with big fish all around?

It's sexier....this is the commerical before the superbowl.

<< Previous

Bullboard Posts

Next >>

Investing with insurance and protection